135 related articles for article (PubMed ID: 11990420)
1. Spontaneous peritoneal catheter extrusion.
Nowicki M; Jander A; Czupryniak A; Kaluzynska A
Perit Dial Int; 2002; 22(2):277-8. PubMed ID: 11990420
[No Abstract] [Full Text] [Related]
2. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J
Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248
[No Abstract] [Full Text] [Related]
3. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment.
Riu S; Ruiz CG; Martinez-Vea A; Peralta C; Oliver JA
Nephrol Dial Transplant; 1998 Jul; 13(7):1870-1. PubMed ID: 9681752
[No Abstract] [Full Text] [Related]
5. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
[TBL] [Abstract][Full Text] [Related]
6. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
[TBL] [Abstract][Full Text] [Related]
7. Shewanella algae Peritonitis in Patients on Peritoneal Dialysis.
Shanmuganathan M; Goh BL; Lim C; NorFadhlina Z; Fairol I
Perit Dial Int; 2016 9-10; 36(5):574-5. PubMed ID: 27659933
[TBL] [Abstract][Full Text] [Related]
8. An analysis of methods to prevent peritoneal dialysis catheter infections.
Piraino B; Bernardini J; Bender FH
Perit Dial Int; 2008; 28(5):437-43. PubMed ID: 18708532
[No Abstract] [Full Text] [Related]
9. Reinsertion of PD catheters during PD-related infections performed either simultaneously or after an intervening period.
Fredensborg BB; Meyer HW; Joffe P; Fugleberg S
Perit Dial Int; 1995; 15(8):374-8. PubMed ID: 8785240
[No Abstract] [Full Text] [Related]
10. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
[TBL] [Abstract][Full Text] [Related]
12. Unusual complications of a polyurethane PD catheter.
Rao SP; Oreopoulos DG
Perit Dial Int; 1997; 17(4):410-2. PubMed ID: 9284480
[No Abstract] [Full Text] [Related]
13. Management of catheter-related infections.
Piraino B
Am J Kidney Dis; 1996 May; 27(5):754-8. PubMed ID: 8629641
[No Abstract] [Full Text] [Related]
14. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
15. Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients.
Vas SI; Conly J; Bargman JM; Oreopoulos DG
Perit Dial Int; 1999; 19(4):313-4. PubMed ID: 10507810
[No Abstract] [Full Text] [Related]
16. Mupirocin once weekly reduces the incidence of catheter exit-site infection in peritoneal dialysis patients.
Al-Hilali NA; Ninan VT; Al-Humoud HA; Nampoory MR; Johny KV
Perit Dial Int; 2005; 25(1):91-2. PubMed ID: 15770932
[No Abstract] [Full Text] [Related]
17. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
19. Erosion of the Silicone Peritoneal Dialysis Catheter with the Use of Gentamicin Cream at the Exit Site.
Gardezi AI; Schlageter KW; Foster DM; Astor BC; Chan MR; Waheed S
Adv Perit Dial; 2016; 32():15-18. PubMed ID: 28988584
[TBL] [Abstract][Full Text] [Related]
20. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
